Atropinic (Anticholinergic) Burden in Parkinson's Disease.

about

Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration.Atropinic (anticholinergic) burden in antipsychotic-treated patients.

P2860

Q30244035-7EC0A389-3DC0-4AD7-A637-FC1B616A69B0 Q48099199-D39014D7-9168-477C-A19A-E3C3CE77424D

P2860

Atropinic (Anticholinergic) Burden in Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q38793600

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Atropinic (Anticholinergic) Burden in Parkinson's Disease.

@en

type

Item

label

Atropinic (Anticholinergic) Burden in Parkinson's Disease.

@en

prefLabel

Atropinic (Anticholinergic) Burden in Parkinson's Disease.

@en

P1476

Atropinic (Anticholinergic) Burden in Parkinson's Disease.

@en

P2093

Antoine Pariente

http://www.w3.org/2001/XMLSchema#string

Bernard Bégaud

http://www.w3.org/2001/XMLSchema#string

Florence Moulis

http://www.w3.org/2001/XMLSchema#string

Haleh Bagheri

http://www.w3.org/2001/XMLSchema#string

Leila Chebane

http://www.w3.org/2001/XMLSchema#string

Sibylle De Germay

http://www.w3.org/2001/XMLSchema#string

Vanessa Rousseau

http://www.w3.org/2001/XMLSchema#string

P2860

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs.

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Future directions in the treatment of Parkinson's disease.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.

Systematic review of anticholinergic risk scales in older adults.

Anticholinergic burden in Parkinson's disease inpatients.

Atropinic burden of prescriptions forms in patients with Alzheimer disease: a cross-sectional study in a French PharmacoVigilance Database.

The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature.

Systematic review on the use of anticholinergic scales in poly pathological patients.

P304

632-636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.26595

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Rascol

Jean-Louis Montastruc

François Montastruc

Emmanuelle Bondon-Guitton

Geneviève Durrieu

P577

2016-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27028036

http://www.w3.org/2001/XMLSchema#string

Atropinic (Anticholinergic) Burden in Parkinson's Disease.

about

P2860

P2860

Atropinic (Anticholinergic) Burden in Parkinson's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698